Terril Brothers’s Biogen BIIB Stock Holding History

Terril Brothers’s Portfolio BIIB Stock Details BIIB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q2	–	Sell	-52,251	Closed	-$12.4M	–	60
2019 Q1	$12.4M	Sell	52,251 -2,661	-5%	-$838K	3.9%	11
2018 Q4	$16.5M	Sell	54,912 -136	-0.2%	-$43.4K	5.93%	5
2018 Q3	$19.4M	Sell	55,048 -822	-1%	-$283K	6%	6
2018 Q2	$16.2M	Sell	55,870 -566	-1%	-$159K	4.99%	8
2018 Q1	$15.5M	Sell	56,436 -1,132	-2%	-$351K	4.69%	9
2017 Q4	$18.3M	Sell	57,568 -347	-0.6%	-$111K	5.65%	8
2017 Q3	$18.1M	Sell	57,915 -168	-0.3%	-$49.7K	5.81%	8
2017 Q2	$15.8M	Sell	58,083 -498	-0.9%	-$132K	5.61%	8
2017 Q1	$16M	Sell	58,581 -640	-1%	-$181K	5.66%	8
2016 Q4	$16.8M	Sell	59,221 -1,090	-2%	-$323K	5.85%	9
2016 Q3	$18.9M	Sell	60,311 -5,262	-8%	-$1.56M	9.98%	5
2016 Q2	$15.9M	Buy	+65,573	New	+$17.3M	7.01%	6

Other funds holding BIIB

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Terril Brothers's BIIB Position: Q2 2019 in Review

Terril Brothers sold out of Biogen (BIIB) in Q2 2019, closing a stake of 52,251 shares — an estimated $12.4M sold.

Terril Brothers first reported a position in BIIB in Q2 2016 and held it in 12 quarters. The position peaked at $19.4M in Q3 2018. 1,010 funds tracked by Wall St. Rank hold BIIB as of Q2 2019.

Terril Brothers reported no remaining Biogen position as of Q2 2019 after selling out during the quarter.
Terril Brothers sold 52,251 Biogen shares in Q2 2019, an estimated $12.4M.
Terril Brothers first reported a position in Biogen in Q2 2016 and held it in 12 quarters.
Terril Brothers's Biogen position peaked at $19.4M in Q3 2018.
1,010 funds tracked by Wall St. Rank held Biogen as of Q2 2019.

Based on Terril Brothers's 13F filing for Q2 2019, filed 5 Aug 2019.